These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11136936)

  • 1. NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species.
    Marshall JW; Duffin KJ; Green AR; Ridley RM
    Stroke; 2001 Jan; 32(1):190-8. PubMed ID: 11136936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.
    Marshall JW; Cummings RM; Bowes LJ; Ridley RM; Green AR
    Stroke; 2003 Sep; 34(9):2228-33. PubMed ID: 12920263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke.
    Peeling J; Del Bigio MR; Corbett D; Green AR; Jackson DM
    Neuropharmacology; 2001 Mar; 40(3):433-9. PubMed ID: 11166336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
    Sydserff SG; Borelli AR; Green AR; Cross AJ
    Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures.
    Marshall JW; Green AR; Ridley RM
    Brain Res; 2003 May; 972(1-2):119-26. PubMed ID: 12711084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke.
    Lees KR; Sharma AK; Barer D; Ford GA; Kostulas V; Cheng YF; Odergren T
    Stroke; 2001 Mar; 32(3):675-80. PubMed ID: 11239186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
    Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
    Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
    Maples KR; Green AR; Floyd RA
    CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR; Ashwood T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia.
    Ginsberg MD; Becker DA; Busto R; Belayev A; Zhang Y; Khoutorova L; Ley JJ; Zhao W; Belayev L
    Ann Neurol; 2003 Sep; 54(3):330-42. PubMed ID: 12953265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.
    Kuroda S; Tsuchidate R; Smith ML; Maples KR; Siesjö BK
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):778-87. PubMed ID: 10413033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
    Han M; He QP; Yong G; Siesjö BK; Li PA
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1249-52. PubMed ID: 14983994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ; Rhoney DH
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.
    Green AR; Lanbeck-Vallén K; Ashwood T; Lundquist S; Lindström Böö E; Jonasson H; Campbell M
    Brain Res; 2006 Feb; 1072(1):224-6. PubMed ID: 16448628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions.
    Dehouck MP; Cecchelli R; Richard Green A; Renftel M; Lundquist S
    Brain Res; 2002 Nov; 955(1-2):229-35. PubMed ID: 12419541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.